Design of CRASH trial. Evidence shows that quality of trial by Faupel et al is good and therefore should not be excluded
BMJ
.
1999 Oct 16;319(7216):1068.
doi: 10.1136/bmj.319.7216.1068a.
Author
P Alderson
PMID:
10521212
PMCID:
PMC1116856
DOI:
10.1136/bmj.319.7216.1068a
No abstract available
Publication types
Comment
Letter
MeSH terms
Adrenal Cortex Hormones / therapeutic use*
Brain Injuries / drug therapy*
Clinical Trials as Topic* / standards
Humans
Substances
Adrenal Cortex Hormones